ACTR2 and Alzheimer disease: Although we did not find differences in the ARP2 intensity per IBA1 cell between AsymAD and AD cases, AsymAD MFGs showed significantly higher levels of ARP2 than did control brains (Fig. 5e), suggesting that AsymAD cases may possess higher baseline levels of ARP2.